Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • ADC Antibody
    (1)
  • Others
    (5)
Filter
Search Result
Results for "

fcr γ

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    6
    TargetMol | Inhibitors_Agonists
  • Inhibitory Antibodies
    6
    TargetMol | Inhibitory_Antibodies
  • Recombinant Protein
    28
    TargetMol | Recombinant_Protein
  • Antibody Products
    7
    TargetMol | Antibody_Products
Rituximab
T9910174722-31-7
Rituximab is an anti-CD20 chimeric monoclonal antibody used to study certain autoimmune diseases and cancers.
  • $229
In Stock
Size
QTY
TargetMol | Inhibitor Hot
Rozanolixizumab
UCB7665
T390571584645-37-3
Rozanolixizumab (RYSTIGGO) is a high-affinity humanized immunoglobulin G4 monoclonal antibody targeting Fc receptors (FcRn) in human newborns for the study of pathogenic IgG in autoimmune and alloimmune diseases.
  • $228
In Stock
Size
QTY
Daratumumab
T9918945721-28-8
Daratumumab is a human monoclonal antibody that targets CD38 a cell surface protein that is overexpressed on multiple myeloma MM) cells.
  • $147
In Stock
Size
QTY
TargetMol | Inhibitor Sale
Alemtuzumab
T9919216503-57-0
Alemtuzumab is a humanized monoclonal antibody against CD52 an antigen found on the surface of normal and malignant lymphocytes.
  • $297
In Stock
Size
QTY
Obinutuzumab
GA101
T9924949142-50-1
Obinutuzumab (Obinutuzumab afutuzumab) GA101) is a glycoengineered Type II CD20 monoclonal antibody in development for non-Hodgkin lymphoma.
  • $247
In Stock
Size
QTY
TargetMol | Inhibitor Sale
Ofatumumab
T9925679818-59-8
Ofatumumab is a fully human monoclonal antibody to CD20 which appears to inhibit early-stage B lymphocyte activation
  • $239
In Stock
Size
QTY